1. In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
   Sara Shayan et al, 2023, Iranian Biomedical Journal CrossRef
2. Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation
   Yong Hu et al, 2017, Tumor Biology CrossRef
3. Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
   Mehrdad Hashemi et al, 2022, Pharmacological Research CrossRef
4. MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells
   Bo Hu et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
5. Linc-ROR has a Potential ceRNA Activity for OCT4A by Sequestering miR-335-5p in the HEK293T Cell Line
   Elham Taheri Bajgan et al, 2022, Biochemical Genetics CrossRef
6. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets
   Cecilia Pop-Bica et al, 2017, International Journal of Molecular Sciences CrossRef
7. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation
   Li-Hui ZHANG et al, 2022, Chinese Journal of Natural Medicines CrossRef
8. N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis
   Jiahe Yi et al, 2024, Cancer Letters CrossRef